PLYX Latest Headlines

Polaryx’s PLX-200 Secures FDA Fast Track for Four LSD Indications—Key Momentum for SOTERIA Trial

Market Chameleon (Tue, 21-Apr 9:07 AM)

FDA Fast Track Designation for PLX-200 Signals Accelerated Path for Polaryx in Rare Pediatric Disorders

Market Chameleon (Tue, 17-Mar 8:42 AM)

Polaryx Therapeutics Strengthens Ties with Krabbe Community Ahead of SOTERIA Trial Initiation

Market Chameleon (Thu, 12-Mar 8:37 AM)

PLYX Advances Clinical Program: SOTERIA Phase 2 Trial Targets Four Rare Diseases

Market Chameleon (Tue, 17-Feb 9:56 AM)

Polaryx Therapeutics Advances SOTERIA Basket Trial with Leading CRO—What This Means for Rare Disease Treatments

Market Chameleon (Tue, 17-Feb 8:42 AM)

Polaryx’s PLX-200 Shows Promising Results in Krabbe Disease: SOTERIA Trial Set to Launch in 2026

Market Chameleon (Tue, 10-Feb 8:47 AM)